OP T LLC has a total of 16 patent applications. Its first patent ever was published in 2018. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Brazil. Its main competitors in its focus markets pharmaceuticals, measurement and biotechnology are NEMETH PETER, BOSTON HEART FOUNDATION INC and BEIJING XINHUALIAN XIEHE PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Analysing materials | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds | |
#5 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Yussman Martin Glenn | 15 |
#2 | Henry Charles W | 15 |
#3 | Wagner Jr David Hal | 7 |
#4 | Wagner Jr | 6 |
#5 | Vaitaitis Gisela M | 3 |
#6 | Wagner David Hal | 2 |
#7 | David Hal Wagner Jr | 1 |
#8 | Martin Glenn Yussman | 1 |
#9 | Charles W Henry | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021011437A1 | Peptides and methods for treating diseases | |
WO2020231948A1 | Diagnosis of multiple sclerosis in human and animal subjects | |
WO2020210726A1 | Diagnosis and treatment of autoimmune diseases | |
US2020297795A1 | Peptides for Treating Disease and Reducing Symptoms Related to Multiple Sclerosis | |
US2020072837A1 | Methods for preventing, modulating and/or reducing cardiovascular disease | |
SG11202006494VA | Therapeutic peptides and methods for treating autoimmune related disease | |
US2019263888A1 | Therapeutic peptides and methods for treating autoimmune related disease | |
WO2019094581A1 | Methods for preventing, modulating and/or reducing cardiovascular disease | |
US2019194290A1 | Methods for preventing, modulating and/or reducing cardiovascular disease |